Systems and methods for measuring cell signaling protein activity
US-2024230643-A9 · Jul 11, 2024 · US
US12534746B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12534746-B2 |
| Application number | US-202017435709-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 5, 2020 |
| Priority date | Mar 8, 2019 |
| Publication date | Jan 27, 2026 |
| Grant date | Jan 27, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure provides fused dimer constructs that enhance fatty acid production and methods for making the dimer constructs. The fused dimer comprises Fab A and/or FabZ enzymes.
Opening claim text (preview).
What is claimed is: 1 . A heterodimer protein, comprising a FabA beta-hydroxyacyl-acyl carrier protein dehydratase subunit (FabA), a FabZ beta-hydroxyacyl-acyl carrier protein dehydratase subunit (FabZ) and a peptide linker, wherein the FabA and FabZ subunits are covalently or non-covalently linked, wherein the peptide linker comprises SEQ ID NO: 15, or a polypeptide with at least 75% identity to SEQ ID NO: 15. 2 . The heterodimer protein of claim 1 , wherein the FabA and the FabZ are fused via the peptide linker to create a covalently-linked heterodimer. 3 . The heterodimer protein of claim 1 , wherein the carboxyl terminus of the FabA subunit is covalently linked to the amino terminus of the peptide linker, and the carboxyl terminus of the peptide linker is covalently linked to the amino terminus of the FabZ subunit. 4 . The heterodimer protein of claim 1 , wherein the carboxyl terminus of the FabZ subunit is covalently linked to the amino terminus of the peptide linker, and the carboxyl terminus of the peptide linker is covalently linked to the amino terminus of the FabA subunit. 5 . The heterodimer protein of claim 1 , wherein the heterodimer is configured to form a FabA-peptide linker-FabZ or a FabZ-peptide linker-FabA configuration. 6 . The heterodimer protein of claim 5 , wherein the FabA-peptide linker-FabZ or FabZ-peptide linker-FabA configuration is a forced heterodimer. 7 . A method for producing fatty acids comprising overexpressing a recombinant expression construct in a cell that encodes a FabA-peptide linker-FabZ or FabZ-peptide linker-FabA heterodimeric protein, wherein the peptide linker comprises SEQ ID NO: 15, or a polypeptide with at least 75% identity to SEQ ID NO: 15, wherein total fatty acid yield is increased compared with a cell expressing FabA or FabZ homodimeric proteins. 8 . The method of claim 7 , wherein the cell is an E. Coli cell. 9 . A method for making a fused heterodimer protein consisting of a FabA beta-hydroxyacyl-acyl carrier protein dehydratase subunit (FabA) a FabZ beta-hydroxyacyl-acyl carrier protein dehydratase subunit (FabZ) and a peptide linker, wherein the peptide linker comprises SEQ ID NO: 15, or a polypeptide with at least 75% identity to SEQ ID NO: 15, comprising the steps of a) amplifying the FabA gene, the FabZ gene, and a peptide linker gene; b) performing sequential PCR reactions to generate heterodimers; c) adding primers at the beginning of PCR reaction IV; d) cloning a construct into expression vectors; e) transforming the expression vectors into a cell; and f) verifying the sequence of the construct. 10 . The method of claim 9 , wherein the FabA or FabZ gene is amplified using a reverse primer that contains an overhang complementary to the 5′ terminus of the peptide linker gene. 11 . The method of claim 9 , wherein the FabA or FabZ gene is amplified using a forward primer containing an additional sequence complementary to the 3′ terminus of the peptide linker gene. 12 . The method of claim 9 , wherein the FabA and FabZ genes containing the overhang are purified. 13 . The method of claim 12 , wherein the purified FabA or FabZ gene with the overhang is fused to the peptide linker to generate a Fab-linker intermediate. 14 . The method of claim 12 , wherein the FabA gene with the overhang complementary to the 5′ terminus of the peptide linker gene is fused with the FabZ gene containing the additional sequence complementary to the 3′ terminus of the peptide linker gene. 15 . The method of claim 13 , wherein a final PCR reaction is used to generate the full length FabA-peptide linker-FabZ construct. 16 . The method of claim 15 , wherein the heterodimer sequence of the fabA-peptide linker-FabZ construct heterodimer sequence is determined and compared to the expected sequence. 17 . The method of claim 9 , wherein the fabZ gene with the overhang complementary to the 5′ terminus of the pfa linker gene is fused with the fabA gene containing the additional sequence complementary to the 3′ terminus of the pfa linker gene and a full length FabZ-peptide linker-FabA construct is generated. 18 . The method of claim 9 , wherein the cell is E. Coli.
3-Hydroxyacyl-[acyl-carrier-protein] dehydratase (4.2.1.59) · CPC title
Lyases (4.) · CPC title
Fatty acids · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.